This tender in no longer available.

Tender description

Supply of ambrisentan tablets to NHS Scotland.

Legal, economic, financial and technical information

List and brief description of selection criteria

(a) potential framework participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered goods at the date of submission of the tender.

(b) potential framework participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.

(c) all tendered Goods must comply with the MHRA best practice guidance on labelling and packaging and the National Patient Safety Agency (‘NPSA’) guidelines on packaging and labelling on pack design.

Minimum level(s) of standards possibly required

(a) confirmation of existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by the MHRA for all tendered goods at the date of submission of the tender should be included in the qualification envelope of the ITT under the technical and professional ability: quality control.

(b) confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the qualification envelope of the ITT under the quality assurance schemes.

(c) confirmation that samples for tendered goods will be supplied upon request to ensure compliance with the MHRA best practice guidance on labelling and packaging and the National Patient Safety Agency (‘NPSA’) guidelines on packaging and labelling on pack design. Confirmation of sample provision should be provided in the qualification envelope of the ITT under technical and professional ability: products.

List and brief description of conditions
Economic operators may be excluded from this competition if they are in breach of any situation referred to in Regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Procedure

Conditions for opening of tenders

2020-08-18

12:00

Type of contest
Open
Date
2020-08-18
The procurement is covered by the Government Procurement Agreement
Yes
The procurement involves the establishment of a framework agreement
YES
Languages in which projects or requests to participate may be drawn up
EN
Local time
12:00

Complementary information

Review body

Sheriff Court House

27 Chambers Street

Edinburgh

EH1 1LB

[email protected]

Electronic invoicing will be accepted
YES
Date of dispatch of this notice
2020-07-10
Electronic payment will be used
YES
This is a recurrent procurement
No
Additional information

The estimated value referred to in Section II.1.5) and II.2.6) covers the thirty (30) month contract duration and the eighteen (18) month extension period of the framework agreement.

The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 35795. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343

The contracting authority does not intend to include a sub-contract clause as part of community benefits (as per Section 25 of the Procurement Reform (Scotland) Act 2014) in this contract for the following reason:

It is not envisaged that sub-contractors will be utilised in delivery of this framework agreement.

The contracting authority does not intend to include any community benefit requirements in this contract for the following reason:

No Community Benefits will be deliverable through the award of this framework agreement.

(SC Ref:625156)

Electonic ordering will be used
YES
Precise information on deadline(s) for review procedures

Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:

An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.

Main CPV code 33600000

Bidding information

Bidding deadline

18 Aug 2020

0 days remaining

Total estimated value

GBP 5.0 million

Locations

United Kingdom, Edinburgh

LOTS ASSOCIATED WITH THIS TENDER

Value

GBP 5.0 million

Supply of ambrisentan 5 mg and 10 mg tablets (in various pack sizes) to NHS Scotland.

Goods are forecast to be supplied to patients predominantly via the Homecare route with nominal exception (0.004 %). There is a requirement for framework participants to supply goods to the nominated homecare suppliers.

The authority intends to award this framework as a single supplier framework per line.

Full details of goods and volumes can be found within the ITT documents.

Main site or place of performance

All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Award criteria

Supply chain

10

90

Description of renewals

This framework includes the option to extend for up to a total period of eighteen (18) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the framework agreement is due to expire.

SIMILAR TENDERS

Ireland : Naas - Pharmaceutical products

Ireland

Value: 1 Euro

Norway : Lillestrøm - Cleaning and polishing products

Norway

Value: 71.0 million Norwegian Krone

United Kingdom : Normanton - Personal care products

United Kingdom of Great Britain and Northern Ireland

Value: 395.2 million Pound Sterling

Norway : Oslo - Scanners

Norway

Value: 1.5 million Norwegian Krone

Germany : Berlin - Personal care products

Germany

Value: Not specified

Malta : Floriana - Medicinal products used in diabetes

Malta

Value: Not specified

United Kingdom : Edinburgh - Orthopaedic implants

United Kingdom of Great Britain and Northern Ireland

Value: 15.0 million Pound Sterling